Author:
Humaidan P.,Ejdrup Bredkjær H.,Bungum L.,Bungum M.,Grøndahl M.L.,Westergaard L.,Yding Andersen C.
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynaecology,Rehabilitation,Reproductive Medicine
Reference56 articles.
1. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A and Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril67, 917–922.
2. Balasch J, Tur R, Creus M, Buxaderas R, Fabregues F, Ballesca JL, Barri PN and Vanrell JA (1994) Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol Endocrinol8, 7–12.
3. Balasch J, Fabregues F, Tur R, Creus M, Casamitjana R, Penarrubia J, Barri PN and Vanrell JA (1995) Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles. Hum Reprod10, 1377–1381.
4. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E and Fauser BC (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab88, 4186–4192.
5. Bracero NJ, Jurema MW, Posada MN, Whelan JG, Garcia JE and Vlahos NP (2001) Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization–embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome. Fertil Steril76, O–245.
Cited by
387 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献